Single‐Subject Network Analysis of FDOPA PET in Parkinson's Disease and Psychosis Spectrum
Human Brain Mapping · 2025
DOI: 10.1002/hbm.70253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Brain Mapping, 2025. Verfasst von Mario Severino und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Information Engineering, University of Padua, Padova, Italy. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Parkinson Disease, Psychotic Disorders, Schizophrenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Greater understanding of individual biological differences is essential for developing more targeted treatment approaches to complex brain disorders. Traditional analysis methods in molecular imaging studies have primarily focused on quantifying tracer binding in specific brain regions, often neglecting inter‐regional functional relationships. In this study, we propose a statistical framework that combines molecular imaging data with perturbation covariance analysis to construct single‐subject networks and investigate individual patterns of molecular alterations. This framework was tested on [18F]‐DOPA PET imaging as a marker of the brain dopamine system in patients with Parkinson's Disease (PD) and schizophrenia to evaluate its ability to classify patients and characterize their disease severity. Our results show that single‐subject networks effectively capture molecular alterations, differentiate individuals with heterogeneous conditions, and account for within‐group variability. Moreover, the approach successfully distinguishes between preclinical and clinical stages of psychosis and identifies the corresponding molecular connectivity changes in response to antipsychotic medications. Mapping molecular imaging networks presents a new and powerful method for characterizing individualized disease trajectories as well as for evaluating treatment effectiveness in future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Information Engineering, University of Padua, Padova, Italy.
- Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
- Centre for Neurodegeneration and Neuroinflammation, Division of Brain Sciences, Imperial College London, London, UK.
- Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Bari, Italy.
- Division of Neuro, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
- Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
ORCID-Profile: Mario Severino, Julia J Schubert
Förderung
- Wellcome Trust
Zitieren
APA
Severino, M., Schubert, J. J., Nordio, G., Giacomel, A., Easmin, R., Lao-Kaim, N. P., Selvaggi, P., Xu, Z., Pereira, J. B., Jauhar, S., Piccini, P., Howes, O., Turkheimer, F., Veronese, M., & FDOPA PET Imaging Working Group Consortium (2025). Single‐Subject Network Analysis of FDOPA PET in Parkinson's Disease and Psychosis Spectrum. Human Brain Mapping. https://doi.org/10.1002/hbm.70253
Vancouver
Severino M, Schubert JJ, Nordio G, Giacomel A, Easmin R, Lao-Kaim NP, et al. Single‐Subject Network Analysis of FDOPA PET in Parkinson's Disease and Psychosis Spectrum. Human Brain Mapping. 2025. doi:10.1002/hbm.70253
BibTeX
@article{Severino2025,
author = {Severino, Mario and Schubert, Julia J and Nordio, Giovanna and Giacomel, Alessio and Easmin, Rubaida and Lao-Kaim, Nick P and Selvaggi, Pierluigi and Xu, Zhilei and Pereira, Joana B and Jauhar, Sameer and Piccini, Paola and Howes, Oliver and Turkheimer, Federico and Veronese, Mattia and FDOPA PET Imaging Working Group Consortium, FDOPA PET Imaging Working Group Consortium},
title = {Single‐Subject Network Analysis of FDOPA PET in Parkinson's Disease and Psychosis Spectrum},
journal = {Human Brain Mapping},
year = {2025},
doi = {10.1002/hbm.70253}
}
EUVIMED